What is Gary Chen, MD?
California Orthopedic Microsurgery Institute (COMSI) is a comprehensive treatment facility dedicated to the diagnosis and management of bone, joint, muscle, and nerve disorders. The institute offers a broad spectrum of services, including specialized sports medicine, advanced hand and microsurgery, and various orthopedic interventions, all delivered by a team of board-certified surgeons. COMSI supports patients requiring both surgical procedures and rehabilitation services across its Southern California locations, emphasizing a commitment to utilizing cutting-edge techniques and providing extensive patient education and outreach.
How much funding has Gary Chen, MD raised?
Gary Chen, MD has raised a total of $136K across 1 funding round:
Debt
$136K
Debt (2021): $136K with participation from PPP
Key Investors in Gary Chen, MD
PPP
Public-Private Partnership
What's next for Gary Chen, MD?
The recent strategic investment signifies a pivotal moment for Gary Chen, MD, and COMSI, indicating a strong market confidence in their operational model and future expansion plans. This influx of capital is expected to fuel advancements in their service offerings, potentially enabling the adoption of new surgical technologies, expanding their geographic reach within Southern California, or enhancing their patient rehabilitation programs. The company's focus on specialized orthopedic care and microsurgery, coupled with this substantial financial backing, suggests a trajectory aimed at solidifying its leadership position and potentially exploring new avenues for patient care innovation.
See full Gary Chen, MD company page
